Latest Cost Control News

Computershare has reported solid first-half results with earnings per share up 3.9%, prompting an upgrade to full-year guidance and a notable dividend increase.

Bravura Solutions has raised its FY26 revenue and cash EBITDA guidance, reflecting robust project engagement and disciplined cost management. The company also plans increased investment in internal technology.

Genetic Signatures has appointed Anne Lockwood as interim Managing Director, bringing extensive financial expertise to guide the company through a critical transition period.

Jcurve Solutions has reported a robust first half of FY26, posting a 32% increase in revenue and a remarkable 478% jump in EBITDA, while upgrading its full-year revenue guidance amid ongoing customer churn challenges.

Briscoe Group Limited has reported record sales for both the fourth quarter and full-year 2026, alongside improved gross margins and a growing online presence.

GrainCorp has lowered its FY26 earnings guidance, citing persistent global oversupply and weak grain prices that are squeezing margins and volumes. The agribusiness is accelerating cost controls while maintaining a strong balance sheet to navigate these headwinds.

Zimplats reported a 15% year-on-year rise in mined volumes and a 6% quarter-on-quarter reduction in operating cash costs per ounce, while advancing key infrastructure projects on schedule.

Mayfield Childcare Limited reported stable revenue and improved profitability in Q4 FY25, outpacing peers in occupancy growth while rejecting a takeover offer from Embark Early Education.

Pure Foods Tasmania has reported a profitable quarter with improved margins and strategic growth moves, including a new contract packing deal and the acquisition of premium ice cream brand Elato.

Austral Gold Limited has restarted commercial production at its Casposo mine, driving a 170% surge in quarterly sales revenue to US$23.8 million and strengthening its financial position with reduced debt and increased cash reserves.

Merino & Co. reported steady progress in Q2 FY26 with growing demand from China and ongoing investments in brand and manufacturing, despite a tightening cash position.

Oakridge International reports solid growth in healthcare technology revenues and product development progress, while navigating a potential legal claim from Teko International.